Baystreet.ca News Commentary – Pharmaceutical markets are witnessing drug delivery devices surge toward $862.16 billion by ...

PODD gains momentum as Omnipod 5 adoption accelerates, margins scale, and earnings estimates rise despite macro and concentration risks.

Despite an Insulet stake reduction by a major fund, analysts maintain a 'Moderate Buy' rating. Discover why institutional ...

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today December 31st: Great ...

Many investors pay attention to mid-cap stocks because they have established business models and expansive market ...

Get the latest U.S. stock market and healthcare sector updates, key company news, and top healthcare winners and losers.

Despite record beef prices linked to a country-wide cattle shortage, long lines formed at butcher shops Tuesday. TMJ4 spoke with some in line to hear how the price hike is affecting their wallets.

For over four decades, holiday lights over Avenue N have been an enduring tradition that made the area shine for the holidays.

Explore MiniMed Group, Inc.'s upcoming IPO, market position in diabetes devices, and key financial risks. Click for this MMED ...

Insulet Corporation (NASDAQ:PODD) is one of the best growth stocks to buy in 2026. On December 18, Truist lowered the firm’s ...

Insulet Corporation (NASDAQ:PODD) develops, manufactures, and sells insulin delivery systems for people with ...

First Amendment: Congress shall make no law respecting an establishment of religion, or prohibiting the free exercise thereof; or abridging the freedom of speech, or of the press; or the right of the ...